Paul Tudor Jones’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Sell
490,100
-248,500
-34% -$5.35M 0.02% 649
2026
Q1
$8.47M Buy
738,600
+718,000
+3,485% +$10.1M 0.02% 834
2025
Q4
$296K Buy
20,600
+6,000
+41% +$104K ﹤0.01% 3062
2025
Q3
$276K Sell
14,600
-11,200
-43% -$185K ﹤0.01% 3029
2025
Q2
$553K Buy
+25,800
New +$384K ﹤0.01% 2538
2025
Q1
Sell
-37,800
Closed -$508K 3501
2024
Q4
$508K Buy
37,800
+19,000
+101% +$306K ﹤0.01% 2229
2024
Q3
$399K Sell
18,800
-9,000
-32% -$162K ﹤0.01% 2161
2024
Q2
$440K Buy
+27,800
New +$511K ﹤0.01% 1857

Other funds holding OSCR

Paul Tudor Jones's OSCR Position: Q2 2026 in Review

Paul Tudor Jones reduced its Oscar Health (OSCR) stake by 41% in Q2 2026, selling an estimated $15.1M and leaving 1,018,792 shares worth $29.1M. The position accounts for 0.04% of the portfolio, ranked #341.

Paul Tudor Jones first reported a position in OSCR in Q1 2021 and has held it in 19 quarters since. The position peaked at $31.6M in Q3 2025. 401 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Paul Tudor Jones held 1,018,792 shares of Oscar Health worth $29.1M as of Q2 2026.
  • Paul Tudor Jones sold 702,002 Oscar Health shares in Q2 2026, an estimated $15.1M.
  • Oscar Health made up 0.04% of Paul Tudor Jones's portfolio in Q2 2026, its #341 holding.
  • Paul Tudor Jones first reported a position in Oscar Health in Q1 2021 and has held it in 19 quarters since.
  • Paul Tudor Jones's Oscar Health position peaked at $31.6M in Q3 2025.
  • 401 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.